We are reinventing the fundamental science underlying the development of new medicines and their use in individual patients.
The Laboratory of Systems Pharmacology (LSP) uses a team science approach to advance the fundamental science and technology needed to develop new medicines and personalized patient care.
We study the molecular causes of disease, how drugs exert their therapeutic and adverse effects, how clinical trials are designed and interpreted, and how machine learning and AI can help identify new molecular targets in diseases like cancer, Alzheimer’s, tuberculosis, and chronic pain.
The LSP is a research and education program that is part of the Harvard Program in Therapeutic Science (HiTS). Our organization prepares students and fellows for leadership roles in academic research, industry, and government service.
Explore LSP Research
Twitter @Harvard_Lab
.@EllieRand3 (@harvardmed) etal developed a new targeted #Phage Discovery method based on multiple fluorescent markers, allowing for co-culture w/ multiple hosts & visualization of phages — no more selecting only for dominant phages in samples!
https://buff.ly/41dkOdN
Please join us Tomorrow, Dec 3rd, for the next #RegSci Forum with guest speaker Marc Lipsitch @mlipsitch, of @HarvardChanSPH! Find registration information below.
We are thankful to have partnered with @RareCyte for the Orion platform. It would not have been possible without @theNCI SBIR funding!
We've long been able to find new phages and figure out what they interact with.
But what about the other way: if you have a gene, like an antibiotic resistance efflux pump, or a phage defense system, and you want to find phages that do or do not interact with it?
Now you can!